Brief: Abionyx Pharma Signs Agreement To Buy IRIS Pharma Holding

Abionyx Pharma SA

17/11/2021 18:04

Nov 17 (Reuters) - Abionyx Pharma SA  ABNX.PA :
    * SIGNING OF AN AGREEMENT FOR THE CONTRIBUTION OF 100% OF
THE
CAPITAL OF IRIS PHARMA HOLDING
    * ANNOUNCES THE LAUNCH OF A CAPITAL INCREASE IN CASH OF
AROUND 5
MILLION EUROS BY PRIVATE PLACEMENT
    * CONTRIBUTION FINANCED BY NEW ABIONYX SHARE ISSUE AT 3.60
EUR PER
SHARE
    * IRIS PHARMA HOLDING VALUE FIXED AT 5 MILLION EUROS
    * THIS CAPITAL INCREASE IN CASH IS ALREADY THE SUBJECT OF
COMMITMENTS TO SUBSCRIBE FOR MORE THAN 75% OF IT
    * IRIS PHARMA TO BECOME ABIONYX PHARMA'S UNIT
    * THE SUBSCRIPTION PERIOD WILL START ON NOVEMBER 18, 2021
AND WILL
END ON DECEMBER 1, 2021 INCLUSIVE AT THE LATEST, IT BEING
SPECIFIED THAT THIS PERIOD WILL BE CLOSED BY ANTICIPATION IN
CASE OF RECEPTION OF ALL THE SUBSCRIPTIONS BEFORE THIS DATE
    * PIERRE-PAUL ELENA, JOINS ABIONYX PHARMA AS CHIEF
SCIENTIFIC
OFFICER
    * IRIS PHARMA OPERATION TO BE FINALIZED BEFORE YEAR-END

Further company coverage:  ABNX.PA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))